CORONAPHOBIA IN PARAGUAY: SPANISH VALIDATION OF THE COVID-19 PHOBIA SCALE

Imagem de Miniatura
Arquivos
art_TORALES_CORONAPHOBIA_IN_PARAGUAY_SPANISH_VALIDATION_OF_THE_COVID19_2022.PDF (790.7 KB)
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2022
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
MEDICINSKA NAKLADA
Autores
TORALES, Julio
RIOS-GONZALEZ, Carlos
O'HIGGINS, Marcelo
ALMIRON-SANTACRUZ, Jose
GARCIA, Oscar
VENTRIGLIO, Antonio
BARRIOS, Ivan
Citação
PSYCHIATRIA DANUBINA, v.34, n.1, p.126-132, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: The COVID-19 is a highly transmissible disease caused by a new zoonotic coronavirus called SARS-CoV-2 that has led to several health, social, and economic issues worldwide. Anxiety and stress are predominant symptoms in the population during the quarantine; also, levels of fear or phobia have been reported. Subjects and methods: This study validate the Spanish version of the COVID-19 Phobia Scale (C19P-S). Participants were recruited using an Internet-based survey. The survey was open from July 20 to July 31, 2021 and 1079 subjects were included. Results: Kaiser-Meyer-Olkin test was adequate (KMO=0.956) and sphericity tested significantly (p<0.0001). The model of adjustment was good as shown by fit indices (S-B chi(2) =351.67, df=164, p>0.05; RMSEA=0.033; SRMSR=0.042; CFI=0.995, NFI=0.990). Conclusions: This confirms that the model of the Spanish version of the C19P-S may reproduce the same four-factors model from the original version of the scale and all items of these factors reported standardized loadings higher than 0.40 (p<0.001).
Palavras-chave
COVID-19, COVID-19 Phobia Scale, validity, reliability, factor analysis
URI
https://observatorio.fm.usp.br/handle/OPI/47303
Referências
  1. Ahorsu DK, 2020, INT J MENT HEALTH AD, DOI 10.1007/s11469-020-00270-8
  2. Almeida M, 2020, ARCH WOMEN MENT HLTH, V23, P741, DOI 10.1007/s00737-020-01092-2
  3. American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI [DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]
  4. Ammar A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240204
  5. Arpaci I, 2022, DEATH STUD, V46, P553, DOI 10.1080/07481187.2020.1848945
  6. Arpaci I, 2020, PERS INDIV DIFFER, V164, DOI 10.1016/j.paid.2020.110108
  7. Bauerle A, 2020, J PUBLIC HEALTH-UK, V42, P672, DOI 10.1093/pubmed/fdaa106
  8. Barrios I, 2021, IRISH J PSYCHOL MED, V38, P266, DOI 10.1017/ipm.2021.5
  9. Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014
  10. Bilgic S, 2022, DEATH STUD, V46, P590, DOI 10.1080/07481187.2021.1924897
  11. Choi EPH, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103740
  12. Chu IYH, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa192
  13. Cohen J., 2013, STAT POWER ANAL BEHA, DOI 10.4324/9780203771587
  14. Daly Z, 2021, PSYCHIAT RES, V295, DOI 10.1016/j.psychres.2020.113631
  15. Deng J, Ann N Y Acad Sci, V1486, P90
  16. Dror AA, 2020, EUR J EPIDEMIOL, V35, P775, DOI 10.1007/s10654-020-00671-y
  17. Elmer T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236337
  18. Fanaj N, 2021, PSYCHIAT DANUB, V33, P95, DOI 10.24869/psyd.2021.95
  19. Galea S, 2020, JAMA INTERN MED, V180, P817, DOI 10.1001/jamainternmed.2020.1562
  20. Garcia-Campayo J, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-8
  21. Gloster AT, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244809
  22. Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93
  23. Grolli RE, 2021, MOL NEUROBIOL, V58, P1905, DOI 10.1007/s12035-020-02249-x
  24. He YF, 2021, PSYCHIAT DANUB, V33, P76, DOI 10.24869/psyd.2021.76
  25. Heitzman J, 2020, PSYCHIATR POL, V54, P187, DOI 10.12740/PP/120373
  26. Hossain Md Mahbub, 2020, F1000Res, V9, P636, DOI 10.12688/f1000research.24457.1
  27. Kaparounaki CK, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113111
  28. Khan M, 2021, MOLECULES, V26, DOI 10.3390/molecules26010039
  29. Kontoangelos K, 2020, PSYCHIAT INVEST, V17, P491, DOI 10.30773/pi.2020.0161
  30. Labrague LJ, 2020, J NURS MANAGE, V28, P1653, DOI 10.1111/jonm.13121
  31. Liu JL, 2020, J MED VIROL, V92, P1484, DOI 10.1002/jmv.25965
  32. Love J, 2019, J STAT SOFTW, V88, P1, DOI 10.18637/jss.v088.i02
  33. Marano G, Psychiatr Danub, V2021, P124
  34. Meda N, 2021, J PSYCHIATR RES, V134, P69, DOI 10.1016/j.jpsychires.2020.12.045
  35. Navarro SRM, 2014, MEDWAVE, V14, DOI 10.5867/medwave.2014.06.5995
  36. Newby JM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236562
  37. Nussbaumer-Streit B, 2020, Cochrane Database Syst Rev, V2020
  38. Ruiz MA, 2011, J AFFECT DISORDERS, V128, P277, DOI 10.1016/j.jad.2010.07.010
  39. Saltzman LY, 2020, PSYCHOL TRAUMA-US, V12, pS55, DOI 10.1037/tra0000703
  40. Ardestani SMS, 2021, INT J MENT HEALTH AD, DOI 10.1007/s11469-021-00523-0
  41. Schermelleh-Engel K., 2003, METHODS PSYCHOL RES, V8, P23
  42. Sediri S, 2020, ARCH WOMEN MENT HLTH, V23, P749, DOI 10.1007/s00737-020-01082-4
  43. Sharma P, 2020, INDIAN J PUBLIC HLTH, V64, P251, DOI 10.4103/ijph.IJPH_498_20
  44. Shevlin M, 2020, BRIT J HEALTH PSYCH, V25, P875, DOI 10.1111/bjhp.12430
  45. Skoda EM, 2021, BUNDESGESUNDHEITSBLA, V64, P322, DOI 10.1007/s00103-021-03278-0
  46. Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
  47. Torales J, 2016, INT J CULT MENT HLTH, V9, P233, DOI [10.1080/17542863.2016.1197290, DOI 10.1080/17542863.2016.1197290]
  48. Torales J, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.558691
  49. Vindegaard N, 2020, BRAIN BEHAV IMMUN, V89, P531, DOI 10.1016/j.bbi.2020.05.048

Coleções
Artigos e Materiais de Revistas Científicas - FM/Outros
Artigos e Materiais de Revistas Científicas - COVID-19
Artigos e Materiais de Revistas Científicas - LIM/23
Artigos e Materiais de Revistas Científicas - ODS/03